The role of hepatitis B vaccine challenge dose in patients with underlying health conditions
We have evaluated the immunological response to Hepatitis B virus (HBV) booster vaccine dose in 129 adults with underlying diseases in comparison with 694 subjects at occupational risk of infection, who have previously completed the primary series and resulted with anti-HBs <10 mIU/mL. After boos...
Main Authors: | L. Sticchi, I. G. Iavarone, P. Durando, A. Di Biagio, I. Schiavetti, F. Murgia, G. Icardi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-02-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1777058 |
Similar Items
-
Vaccination Campaign against Hepatitis B Virus in Italy: A History of Successful Achievements
by: Tommaso Stroffolini, et al.
Published: (2023-09-01) -
Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01) -
Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus
by: Silvia Cocchio, et al.
Published: (2021-04-01) -
Could mandatory vaccination increase coverage in health-care Workers? The experience of Bari Policlinico General Hospital
by: Antonio Di Lorenzo, et al.
Published: (2021-12-01) -
Hepatitis B vaccination in leprosy patients
by: Heitor Rosa, et al.
Published: (1994-09-01)